About Spiderwort
Spiderwort is a company based in Ottawa (Canada) founded in 2017. Spiderwort has raised $16.08 million across 3 funding rounds from investors including Horizons Ventures, K5 Global and Break Off. Spiderwort offers products and services including CelluBridge and CelluJuve. Spiderwort operates in a competitive market with competitors including Renewcell, RevBio, Spinnova, Dimension Inx and ECOR Global, among others.
- Headquarter Ottawa, Canada
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spiderwort Biotechnologies Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.08 M (USD)
in 3 rounds
-
Latest Funding Round
$13.2 M (USD), Series A
Jul 12, 2022
-
Investors
Horizons Ventures
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spiderwort
Spiderwort offers a comprehensive portfolio of products and services, including CelluBridge and CelluJuve.
Scaffold for supporting spinal cord repair and regeneration.
Filler for facial tissue augmentation and rejuvenation purposes.
People of Spiderwort
Unlock access to complete
Funding Insights of Spiderwort
Spiderwort has successfully raised a total of $16.08M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $13.2 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Spiderwort
Spiderwort has secured backing from 7 investors, including venture fund and angel investors. Prominent investors backing the company include Horizons Ventures, K5 Global and Break Off.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Horizons Ventures is focused on investing in deep science and technology.
|
Locked | Locked | Locked | |
|
Conventional venture capital fund
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Spiderwort
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spiderwort
Investment portfolio details for Spiderwort
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spiderwort
Detailed financials for Spiderwort
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spiderwort Comparisons
Peer comparison for Spiderwort
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spiderwort
Spiderwort operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Renewcell, RevBio, Spinnova, Dimension Inx and ECOR Global, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biodegradable fibres are produced from recycled cellulosic materials.
|
|
| Locked | Locked | Locked |
Synthetic adhesives for bone and dental repair are developed.
|
|
| Locked | Locked | Locked |
Developer of cellulose-based textile fibres
|
|
| Locked | Locked | Locked |
3D biomaterials are provided for regenerative medicine applications.
|
|
| Locked | Locked | Locked |
Sustainable building materials are developed from recycled cellulose fibers.
|
|
| Locked | Locked | Locked |
Developer of biodegradable temporising matrix for treating traumatic wounds
|
Detailed competitors of Spiderwort
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spiderwort
Complete news archive for Spiderwort
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spiderwort
Spiderwort was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Spiderwort is headquartered in Ottawa, Canada. It is registered at Ottawa, Ontario, Canada.
Spiderwort is a funded company, having raised a total of $16.08M across 3 funding rounds to date.
Spiderwort was founded in 2017 in Ottawa, Canada, within the biotechnology sector. Plant-based biomaterials are developed for tissue repair and regeneration, utilizing an open-source platform that employs plant-derived cellulose to form scaffold architectures for organs. Products include CelluBridge, a biomaterial for spinal cord repair, and CelluJuve, a dermal filler for injury recovery and cosmetic applications. Operations focus on advancing regenerative technologies through sustainable materials.
Spiderwort's top competitors include RevBio, Spinnova and ECOR Global.
Spiderwort offers CelluBridge and CelluJuve.
Spiderwort has 7 investors. Key investors include Horizons Ventures, K5 Global, Break Off, Capital Angel Network, and Anges Québec.